Abdominal pain in patient with antiphospholipid syndrome—the role of MDCT angiography on visceral blood vessels
Antiphospholipid syndrome (APS) is an autoimmune disease defined by accelerated atherosclerosis, arterial and venous thrombosis, fetal loss, and the presence of antiphospholipid antibodies (aPL) in the serum and which leads to the occurrence of various vascular events. Nonspecific abdominal pain can...
Gespeichert in:
Veröffentlicht in: | Immunologic research 2017-12, Vol.65 (6), p.1150-1155 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1155 |
---|---|
container_issue | 6 |
container_start_page | 1150 |
container_title | Immunologic research |
container_volume | 65 |
creator | Saponjski, Jovica Stojanovich, Ljudmila Saponjski, Jelena Mirilovic, Milorad Saponjski, Dusan |
description | Antiphospholipid syndrome (APS) is an autoimmune disease defined by accelerated atherosclerosis, arterial and venous thrombosis, fetal loss, and the presence of antiphospholipid antibodies (aPL) in the serum and which leads to the occurrence of various vascular events. Nonspecific abdominal pain can be one of the symptoms due to changes on visceral blood vessels. The goal of our work is to show the results we obtained in multidetector computed tomography (MDCT) angiography examination of visceral arteries, comparing patients with primary antiphospholipid syndrome (PAPS) and secondary antiphospholipid syndrome (SAPS) with control group. In this study, we analyzed 50 patients with primary PAPS and 50 patients, with secondary SAPS. The results were compared to 50 patients in the control group. The groups were compared in terms of age, gender, and the most common risk factors except for the lipid status, since controls had significantly higher levels of cholesterol and triglycerides. The study was conducted on 64-MDCT, on which we analyzed quantitative and morphological characteristics of the blood vessel lesions. Patients from the control group had statistically significant elevation of cholesterol and triglyceride levels compared to the patients with SAPS and PAPS (
p
|
doi_str_mv | 10.1007/s12026-017-8968-1 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1964272544</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1963302429</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-991796783214f0fd95a24f402e8defb5e80a8a7920e362affdcb1e91b4dfbaf53</originalsourceid><addsrcrecordid>eNp1kcFOGzEQhq2qqKRpH6AXZKkXLgu2116vjyhQigTikkq9Wd54nBjtrhd7A8qNh-AJ-yQ4JK0qJCSPfJhvflvzIfSNkhNKiDxNlBFWFYTKolZVXdAPaEKFUAWRQnxEE8KELJiUvw_R55TuCKEV5-UndMgULbmo5ATdnzU2dL43LR6M73E-gxk99CN-9OMKm370wyqkXK0fvMVp09sYOvjz9DyuAMfQAg4O35zP5hle-rCMZlhtcOjxg08LiDm5aUOw-AFSgjZ9QQfOtAm-7u8p-vXjYj77WVzfXl7Nzq6LRSnZWChFpapkXTLKHXFWCcO444RBbcE1AmpiaiMVI1BWzDhnFw0FRRtuXWOcKKfoeJc7xHC_hjTqbvuftjU9hHXSVFWcSSbyRqbo-xv0Lqxj3skrVZaEcaYyRXfUIoaUIjg9RN-ZuNGU6K0PvfOhsw-99aFpnjnaJ6-bDuy_ib8CMsB2QMqtfgnxv6ffTX0BWRiYDg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1963302429</pqid></control><display><type>article</type><title>Abdominal pain in patient with antiphospholipid syndrome—the role of MDCT angiography on visceral blood vessels</title><source>Springer journals</source><creator>Saponjski, Jovica ; Stojanovich, Ljudmila ; Saponjski, Jelena ; Mirilovic, Milorad ; Saponjski, Dusan</creator><creatorcontrib>Saponjski, Jovica ; Stojanovich, Ljudmila ; Saponjski, Jelena ; Mirilovic, Milorad ; Saponjski, Dusan</creatorcontrib><description><![CDATA[Antiphospholipid syndrome (APS) is an autoimmune disease defined by accelerated atherosclerosis, arterial and venous thrombosis, fetal loss, and the presence of antiphospholipid antibodies (aPL) in the serum and which leads to the occurrence of various vascular events. Nonspecific abdominal pain can be one of the symptoms due to changes on visceral blood vessels. The goal of our work is to show the results we obtained in multidetector computed tomography (MDCT) angiography examination of visceral arteries, comparing patients with primary antiphospholipid syndrome (PAPS) and secondary antiphospholipid syndrome (SAPS) with control group. In this study, we analyzed 50 patients with primary PAPS and 50 patients, with secondary SAPS. The results were compared to 50 patients in the control group. The groups were compared in terms of age, gender, and the most common risk factors except for the lipid status, since controls had significantly higher levels of cholesterol and triglycerides. The study was conducted on 64-MDCT, on which we analyzed quantitative and morphological characteristics of the blood vessel lesions. Patients from the control group had statistically significant elevation of cholesterol and triglyceride levels compared to the patients with SAPS and PAPS (
p
< 0.001 and
p
< 0.05). The results showed that the frequency of changes is statistically (
p
< 0.05 and
p
< 0.001) more common in patients with PAPS and SAPS than in the control group. Statistically significant difference between the groups was found in superior and inferior mesentery arteries. Analyzing the number of lesions, there was statistically high difference between the patients with one and two lesions than in patients with four or more lesions (
p
< 0.001), lower difference compared to the patients with three lesions (
p
< 0.01), while there was low, but yet statistically important difference between the patients with three lesions and those with five or more blood vessel lesions (
p
< 0.05). Analyzing percentage of diameter stenosis, we established that the lesions in the groups of 0–30% diameter stenosis (DS) and 30–50% DS in patients with PAPS (
n
= 42) and SAPS (
n
= 44) are more common than in the control group (
n
= 18,
p
< 0.05). Analyzing the qualitative characteristics of plaques, we established significantly higher frequency of soft tissue and mixed lesions than calcified ones in patients with PAPS and SAPS (
p
< 0.001;
p
< 0.05). Our study showed that the subclinical manifestation of the changes on visceral arteries is more common in patients with APS. Patients with abdominal pain were those with two or more lesions, and according to our results, majority had PAPS. Because of its safety and accuracy, the method of choice is MDCT angiography in monitoring the progression of disease.]]></description><identifier>ISSN: 0257-277X</identifier><identifier>EISSN: 1559-0755</identifier><identifier>DOI: 10.1007/s12026-017-8968-1</identifier><identifier>PMID: 29134567</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Abdomen ; Allergology ; Angiography ; Antibodies ; Antiphospholipid antibodies ; Antiphospholipid syndrome ; Arteries ; Arteriosclerosis ; Atherosclerosis ; Autoimmune diseases ; Biomedical and Life Sciences ; Biomedicine ; Blood vessels ; Cholesterol ; Computed tomography ; Fetuses ; Immunology ; Internal Medicine ; Lesions ; Medical imaging ; Medicine/Public Health ; Mesentery ; Original Article ; Pain ; Patients ; Physical characteristics ; Plaques ; Qualitative analysis ; Risk analysis ; Risk factors ; Statistical analysis ; Statistical significance ; Stenosis ; Thromboembolism ; Thrombosis ; Triglycerides ; Veins & arteries</subject><ispartof>Immunologic research, 2017-12, Vol.65 (6), p.1150-1155</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2017</rights><rights>Immunologic Research is a copyright of Springer, (2017). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-991796783214f0fd95a24f402e8defb5e80a8a7920e362affdcb1e91b4dfbaf53</citedby><cites>FETCH-LOGICAL-c372t-991796783214f0fd95a24f402e8defb5e80a8a7920e362affdcb1e91b4dfbaf53</cites><orcidid>0000-0002-6640-234X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12026-017-8968-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12026-017-8968-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29134567$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saponjski, Jovica</creatorcontrib><creatorcontrib>Stojanovich, Ljudmila</creatorcontrib><creatorcontrib>Saponjski, Jelena</creatorcontrib><creatorcontrib>Mirilovic, Milorad</creatorcontrib><creatorcontrib>Saponjski, Dusan</creatorcontrib><title>Abdominal pain in patient with antiphospholipid syndrome—the role of MDCT angiography on visceral blood vessels</title><title>Immunologic research</title><addtitle>Immunol Res</addtitle><addtitle>Immunol Res</addtitle><description><![CDATA[Antiphospholipid syndrome (APS) is an autoimmune disease defined by accelerated atherosclerosis, arterial and venous thrombosis, fetal loss, and the presence of antiphospholipid antibodies (aPL) in the serum and which leads to the occurrence of various vascular events. Nonspecific abdominal pain can be one of the symptoms due to changes on visceral blood vessels. The goal of our work is to show the results we obtained in multidetector computed tomography (MDCT) angiography examination of visceral arteries, comparing patients with primary antiphospholipid syndrome (PAPS) and secondary antiphospholipid syndrome (SAPS) with control group. In this study, we analyzed 50 patients with primary PAPS and 50 patients, with secondary SAPS. The results were compared to 50 patients in the control group. The groups were compared in terms of age, gender, and the most common risk factors except for the lipid status, since controls had significantly higher levels of cholesterol and triglycerides. The study was conducted on 64-MDCT, on which we analyzed quantitative and morphological characteristics of the blood vessel lesions. Patients from the control group had statistically significant elevation of cholesterol and triglyceride levels compared to the patients with SAPS and PAPS (
p
< 0.001 and
p
< 0.05). The results showed that the frequency of changes is statistically (
p
< 0.05 and
p
< 0.001) more common in patients with PAPS and SAPS than in the control group. Statistically significant difference between the groups was found in superior and inferior mesentery arteries. Analyzing the number of lesions, there was statistically high difference between the patients with one and two lesions than in patients with four or more lesions (
p
< 0.001), lower difference compared to the patients with three lesions (
p
< 0.01), while there was low, but yet statistically important difference between the patients with three lesions and those with five or more blood vessel lesions (
p
< 0.05). Analyzing percentage of diameter stenosis, we established that the lesions in the groups of 0–30% diameter stenosis (DS) and 30–50% DS in patients with PAPS (
n
= 42) and SAPS (
n
= 44) are more common than in the control group (
n
= 18,
p
< 0.05). Analyzing the qualitative characteristics of plaques, we established significantly higher frequency of soft tissue and mixed lesions than calcified ones in patients with PAPS and SAPS (
p
< 0.001;
p
< 0.05). Our study showed that the subclinical manifestation of the changes on visceral arteries is more common in patients with APS. Patients with abdominal pain were those with two or more lesions, and according to our results, majority had PAPS. Because of its safety and accuracy, the method of choice is MDCT angiography in monitoring the progression of disease.]]></description><subject>Abdomen</subject><subject>Allergology</subject><subject>Angiography</subject><subject>Antibodies</subject><subject>Antiphospholipid antibodies</subject><subject>Antiphospholipid syndrome</subject><subject>Arteries</subject><subject>Arteriosclerosis</subject><subject>Atherosclerosis</subject><subject>Autoimmune diseases</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Blood vessels</subject><subject>Cholesterol</subject><subject>Computed tomography</subject><subject>Fetuses</subject><subject>Immunology</subject><subject>Internal Medicine</subject><subject>Lesions</subject><subject>Medical imaging</subject><subject>Medicine/Public Health</subject><subject>Mesentery</subject><subject>Original Article</subject><subject>Pain</subject><subject>Patients</subject><subject>Physical characteristics</subject><subject>Plaques</subject><subject>Qualitative analysis</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>Statistical analysis</subject><subject>Statistical significance</subject><subject>Stenosis</subject><subject>Thromboembolism</subject><subject>Thrombosis</subject><subject>Triglycerides</subject><subject>Veins & arteries</subject><issn>0257-277X</issn><issn>1559-0755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp1kcFOGzEQhq2qqKRpH6AXZKkXLgu2116vjyhQigTikkq9Wd54nBjtrhd7A8qNh-AJ-yQ4JK0qJCSPfJhvflvzIfSNkhNKiDxNlBFWFYTKolZVXdAPaEKFUAWRQnxEE8KELJiUvw_R55TuCKEV5-UndMgULbmo5ATdnzU2dL43LR6M73E-gxk99CN-9OMKm370wyqkXK0fvMVp09sYOvjz9DyuAMfQAg4O35zP5hle-rCMZlhtcOjxg08LiDm5aUOw-AFSgjZ9QQfOtAm-7u8p-vXjYj77WVzfXl7Nzq6LRSnZWChFpapkXTLKHXFWCcO444RBbcE1AmpiaiMVI1BWzDhnFw0FRRtuXWOcKKfoeJc7xHC_hjTqbvuftjU9hHXSVFWcSSbyRqbo-xv0Lqxj3skrVZaEcaYyRXfUIoaUIjg9RN-ZuNGU6K0PvfOhsw-99aFpnjnaJ6-bDuy_ib8CMsB2QMqtfgnxv6ffTX0BWRiYDg</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>Saponjski, Jovica</creator><creator>Stojanovich, Ljudmila</creator><creator>Saponjski, Jelena</creator><creator>Mirilovic, Milorad</creator><creator>Saponjski, Dusan</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6640-234X</orcidid></search><sort><creationdate>20171201</creationdate><title>Abdominal pain in patient with antiphospholipid syndrome—the role of MDCT angiography on visceral blood vessels</title><author>Saponjski, Jovica ; Stojanovich, Ljudmila ; Saponjski, Jelena ; Mirilovic, Milorad ; Saponjski, Dusan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-991796783214f0fd95a24f402e8defb5e80a8a7920e362affdcb1e91b4dfbaf53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Abdomen</topic><topic>Allergology</topic><topic>Angiography</topic><topic>Antibodies</topic><topic>Antiphospholipid antibodies</topic><topic>Antiphospholipid syndrome</topic><topic>Arteries</topic><topic>Arteriosclerosis</topic><topic>Atherosclerosis</topic><topic>Autoimmune diseases</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Blood vessels</topic><topic>Cholesterol</topic><topic>Computed tomography</topic><topic>Fetuses</topic><topic>Immunology</topic><topic>Internal Medicine</topic><topic>Lesions</topic><topic>Medical imaging</topic><topic>Medicine/Public Health</topic><topic>Mesentery</topic><topic>Original Article</topic><topic>Pain</topic><topic>Patients</topic><topic>Physical characteristics</topic><topic>Plaques</topic><topic>Qualitative analysis</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>Statistical analysis</topic><topic>Statistical significance</topic><topic>Stenosis</topic><topic>Thromboembolism</topic><topic>Thrombosis</topic><topic>Triglycerides</topic><topic>Veins & arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saponjski, Jovica</creatorcontrib><creatorcontrib>Stojanovich, Ljudmila</creatorcontrib><creatorcontrib>Saponjski, Jelena</creatorcontrib><creatorcontrib>Mirilovic, Milorad</creatorcontrib><creatorcontrib>Saponjski, Dusan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Immunologic research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saponjski, Jovica</au><au>Stojanovich, Ljudmila</au><au>Saponjski, Jelena</au><au>Mirilovic, Milorad</au><au>Saponjski, Dusan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Abdominal pain in patient with antiphospholipid syndrome—the role of MDCT angiography on visceral blood vessels</atitle><jtitle>Immunologic research</jtitle><stitle>Immunol Res</stitle><addtitle>Immunol Res</addtitle><date>2017-12-01</date><risdate>2017</risdate><volume>65</volume><issue>6</issue><spage>1150</spage><epage>1155</epage><pages>1150-1155</pages><issn>0257-277X</issn><eissn>1559-0755</eissn><abstract><![CDATA[Antiphospholipid syndrome (APS) is an autoimmune disease defined by accelerated atherosclerosis, arterial and venous thrombosis, fetal loss, and the presence of antiphospholipid antibodies (aPL) in the serum and which leads to the occurrence of various vascular events. Nonspecific abdominal pain can be one of the symptoms due to changes on visceral blood vessels. The goal of our work is to show the results we obtained in multidetector computed tomography (MDCT) angiography examination of visceral arteries, comparing patients with primary antiphospholipid syndrome (PAPS) and secondary antiphospholipid syndrome (SAPS) with control group. In this study, we analyzed 50 patients with primary PAPS and 50 patients, with secondary SAPS. The results were compared to 50 patients in the control group. The groups were compared in terms of age, gender, and the most common risk factors except for the lipid status, since controls had significantly higher levels of cholesterol and triglycerides. The study was conducted on 64-MDCT, on which we analyzed quantitative and morphological characteristics of the blood vessel lesions. Patients from the control group had statistically significant elevation of cholesterol and triglyceride levels compared to the patients with SAPS and PAPS (
p
< 0.001 and
p
< 0.05). The results showed that the frequency of changes is statistically (
p
< 0.05 and
p
< 0.001) more common in patients with PAPS and SAPS than in the control group. Statistically significant difference between the groups was found in superior and inferior mesentery arteries. Analyzing the number of lesions, there was statistically high difference between the patients with one and two lesions than in patients with four or more lesions (
p
< 0.001), lower difference compared to the patients with three lesions (
p
< 0.01), while there was low, but yet statistically important difference between the patients with three lesions and those with five or more blood vessel lesions (
p
< 0.05). Analyzing percentage of diameter stenosis, we established that the lesions in the groups of 0–30% diameter stenosis (DS) and 30–50% DS in patients with PAPS (
n
= 42) and SAPS (
n
= 44) are more common than in the control group (
n
= 18,
p
< 0.05). Analyzing the qualitative characteristics of plaques, we established significantly higher frequency of soft tissue and mixed lesions than calcified ones in patients with PAPS and SAPS (
p
< 0.001;
p
< 0.05). Our study showed that the subclinical manifestation of the changes on visceral arteries is more common in patients with APS. Patients with abdominal pain were those with two or more lesions, and according to our results, majority had PAPS. Because of its safety and accuracy, the method of choice is MDCT angiography in monitoring the progression of disease.]]></abstract><cop>New York</cop><pub>Springer US</pub><pmid>29134567</pmid><doi>10.1007/s12026-017-8968-1</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-6640-234X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0257-277X |
ispartof | Immunologic research, 2017-12, Vol.65 (6), p.1150-1155 |
issn | 0257-277X 1559-0755 |
language | eng |
recordid | cdi_proquest_miscellaneous_1964272544 |
source | Springer journals |
subjects | Abdomen Allergology Angiography Antibodies Antiphospholipid antibodies Antiphospholipid syndrome Arteries Arteriosclerosis Atherosclerosis Autoimmune diseases Biomedical and Life Sciences Biomedicine Blood vessels Cholesterol Computed tomography Fetuses Immunology Internal Medicine Lesions Medical imaging Medicine/Public Health Mesentery Original Article Pain Patients Physical characteristics Plaques Qualitative analysis Risk analysis Risk factors Statistical analysis Statistical significance Stenosis Thromboembolism Thrombosis Triglycerides Veins & arteries |
title | Abdominal pain in patient with antiphospholipid syndrome—the role of MDCT angiography on visceral blood vessels |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T12%3A33%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Abdominal%20pain%20in%20patient%20with%20antiphospholipid%20syndrome%E2%80%94the%20role%20of%20MDCT%20angiography%20on%20visceral%20blood%20vessels&rft.jtitle=Immunologic%20research&rft.au=Saponjski,%20Jovica&rft.date=2017-12-01&rft.volume=65&rft.issue=6&rft.spage=1150&rft.epage=1155&rft.pages=1150-1155&rft.issn=0257-277X&rft.eissn=1559-0755&rft_id=info:doi/10.1007/s12026-017-8968-1&rft_dat=%3Cproquest_cross%3E1963302429%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1963302429&rft_id=info:pmid/29134567&rfr_iscdi=true |